Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
Clinical trial NCT04890353 · TERMINATED
Trial details
- NCT number
- NCT04890353
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-02-08
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.